Transition metals redox: Reviving an old plot for diabetic vascular disease

Journal of Clinical Investigation

Volumn 107, Issue 7, 2001, Pages 799-801

  Monnier, V M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; HYDROXYL RADICAL; METAL; MYELOPEROXIDASE;

CHIMERA; DIABETIC ANGIOPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERGLYCEMIA; LIPID OXIDATION; NONHUMAN; NOTE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0035063226     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12635     Document Type: Note

References (29)

1. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus
2. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes
3. The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not
4. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy
5. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy
6. The antioxidant paradox
7. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents
8. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway
9. Perspectives in diabetes: Hyperglycemic pseudohypoxia and diabetic complications
10. Protein glycation and oxidative stress in diabetes mellitus and ageing
11. Role of oxidative stress in development of complications in diabetes
12. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
13. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes
14. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density lipoprotein hypothesis
15. The mystery of diabetes and atherosclerosis: Time for a new plot
16. A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease
17. Glycoxidation and lipoxidation in atherogenesis
18. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
19. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat
20. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques
21. Hydroxyl radical mediates Ne-(carboxymethyl)lysine formation from Amadori product
22. Protein aging by carboxymethylation of lysines generates redox active and divalent metal binding sites: Relevance to diseases of glycoxidative stress
23. Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: Possible role of advanced glycation end products
24. Glycation of metal containing proteins such as Cu,Zn-superoxide dismutase, ceruloplasmin, and ferritin: Possible implication for DNA damage in vivo
25. Transition metals bind to glycated proteins forming redox active "glycochelates": Implications for the pathogenesis of certain diabetic complications
26. Ceruloplasmin and cardio-vascular disease
27. CD36, a member of class B scavenger receptor family, as a receptor for advanced glycation end products (AGE)
28. Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
29. Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains